agilon health, inc. (NYSE:AGL – Get Rating) was up 4.4% during mid-day trading on Thursday after Wells Fargo & Company raised their price target on the stock from $22.00 to $28.00. The stock traded as high as $25.02 and last traded at $24.97. Approximately 541,831 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 2,141,364 shares. The stock had previously closed at $23.91.
Other analysts have also issued research reports about the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of agilon health from $26.00 to $28.00 in a research report on Friday, March 3rd. Stifel Nicolaus initiated coverage on shares of agilon health in a report on Thursday, December 8th. They set a “buy” rating and a $23.00 target price on the stock. Finally, Guggenheim upped their target price on shares of agilon health from $21.00 to $30.00 and gave the stock a “buy” rating in a report on Monday, March 6th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $29.38.
Insider Transactions at agilon health
In other news, insider Benjamin Kornitzer sold 2,698 shares of the stock in a transaction on Thursday, January 5th. The shares were sold at an average price of $15.51, for a total value of $41,845.98. Following the transaction, the insider now owns 10,426 shares of the company’s stock, valued at approximately $161,707.26. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, insider Benjamin Shaker sold 28,555 shares of the stock in a transaction on Wednesday, February 15th. The shares were sold at an average price of $23.37, for a total value of $667,330.35. Following the transaction, the insider now owns 25,625 shares of the company’s stock, valued at approximately $598,856.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Benjamin Kornitzer sold 2,698 shares of the stock in a transaction on Thursday, January 5th. The stock was sold at an average price of $15.51, for a total transaction of $41,845.98. Following the completion of the transaction, the insider now directly owns 10,426 shares in the company, valued at approximately $161,707.26. The disclosure for this sale can be found here. Insiders have sold 65,466 shares of company stock valued at $1,424,383 in the last quarter. Insiders own 3.30% of the company’s stock.
Hedge Funds Weigh In On agilon health
agilon health Stock Up 9.1 %
The company has a market cap of $10.77 billion, a PE ratio of -100.30 and a beta of 1.09. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.71 and a current ratio of 2.71. The stock’s 50 day moving average price is $21.75 and its 200-day moving average price is $20.38.
About agilon health
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
- Get a free copy of the StockNews.com research report on agilon health (AGL)
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.